et al. Phase I/II safety and antitumor activity of nivolumab in patients with advanced hepatocellular carcinoma (HCC): CA209-040. J. Clin Oncol. Abstr. 33, LBA101 (2015). Article Google Scholar Yeo, W. et al. Epigenetic therapy using belinostat for patients with unresectable hepatocellular...
reduced Fig. 1 Progression of liver disease from MASH to hepatocellular carcinoma via gut–liver axis dysregulation. The figure illustrates the pathological progression from MASH to HCC through disruptions in the gut–liver axis. The MASH liver exhibits alterations in the intestinal barrier and gut mi...
CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef] [PubMed] European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol. 2018, 69, 182–236. [Google Scholar] [CrossRef] [PubMed] Llovet, J.M.;...
Calculations were performed using GraphPad Prism software (GraphPad Software, Inc., San Diego, CA, USA) and SPSS (SPSS Statistics 23, IBM Corp., Armonk, NY, USA). 5. Conclusions In this study, we newly showed that the delta subunit of rod-specific photoreceptor cGMP phosphodiesterase (PDE6D...